WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H527045
CAS#: 22254-24-6 (bromide)
Description: Ipratropium Bromide is a muscarinic antagonist, bronchodilator. N-Isopropylated atropine.
Hodoodo Cat#: H527045
Name: Ipratropium Bromide
CAS#: 22254-24-6 (bromide)
Chemical Formula: C20H30BrNO3
Exact Mass: 411.14
Molecular Weight: 412.368
Elemental Analysis: C, 58.25; H, 7.33; Br, 19.38; N, 3.40; O, 11.64
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Related CAS #: 60205-81-4 (cation) 22254-24-6 (bromide) 66985-17-9 (bromide hydrate) 922491-06-3 (bromide hydrate)
Synonym: Ipratropium Bromide
IUPAC/Chemical Name: (endo,syn)-(±)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane bromide
InChi Key: LHLMOSXCXGLMMN-UHFFFAOYSA-M
InChi Code: InChI=1S/C20H30NO3.BrH/c1-14(2)21(3)16-9-10-17(21)12-18(11-16)24-20(23)19(13-22)15-7-5-4-6-8-15;/h4-8,14,16-19,22H,9-13H2,1-3H3;1H/q+1;/p-1
SMILES Code: CC([N+]1(C)C2CC(OC(C(C3=CC=CC=C3)CO)=O)CC1CC2)C.[Br-]
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
The following data is based on the product molecular weight 412.37 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
1: Bräunlich J, Wirtz H. Oral Versus Nasal High-Flow Bronchodilator Inhalation in Chronic Obstructive Pulmonary Disease. J Aerosol Med Pulm Drug Deliv. 2017 Dec 20. doi: 10.1089/jamp.2017.1432. [Epub ahead of print] PubMed PMID: 29261402.
2: Pejic R, Klaric B. Transient anisocoria in a patient treated with nebulized ipratropium bromide. Am J Ophthalmol Case Rep. 2017 Apr 12;7:11-13. doi: 10.1016/j.ajoc.2017.04.005. eCollection 2017 Sep. PubMed PMID: 29260071; PubMed Central PMCID: PMC5722162.
3: Bar-Aluma BE, Efrati O, Kaufmann H, Palma JA, Norcliffe-Kaufmann L. A Controlled Trial of Inhaled Bronchodilators in Familial Dysautonomia. Lung. 2017 Dec 12. doi: 10.1007/s00408-017-0073-7. [Epub ahead of print] PubMed PMID: 29234869.
4: Jiang DH, Wang X, Liu LS, Ji DD, Zhang N. The effect of ventilator mask atomization inhalation of ipratropium bromide and budesonide suspension liquid in the treatment of COPD in acute exacerbation period on circulating levels of inflammation and prognosis. Eur Rev Med Pharmacol Sci. 2017 Nov;21(22):5211-5216. doi: 10.26355/eurrev_201711_13843. PubMed PMID: 29228436.
5: Knightly R, Milan SJ, Hughes R, Knopp-Sihota JA, Rowe BH, Normansell R, Powell C. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev. 2017 Nov 28;11:CD003898. doi: 10.1002/14651858.CD003898.pub6. Review. PubMed PMID: 29182799.
6: Lin X, Fan Y, Wang X, Chi M, Li X, Zhang X, Sun D. Correlation Between Tumor Necrosis Factor-α and Interleukin-1β in Exhaled Breath Condensate and Pulmonary Function. Am J Med Sci. 2017 Oct;354(4):388-394. doi: 10.1016/j.amjms.2017.06.004. Epub 2017 Jun 12. PubMed PMID: 29078843.
7: Yang SH, Yang TM, Lin HL, Tsai YH, Fang TP, Wan GH. Size distribution of salbutamol/ipratropium aerosols produced by different nebulizers in the absence and presence of heat and humidification. Pulm Pharmacol Ther. 2017 Oct 17. pii: S1094-5539(17)30208-0. doi: 10.1016/j.pupt.2017.10.009. [Epub ahead of print] PubMed PMID: 29054517.
8: Famularo G, Sordillo P, Stasolla A, Parisi MG. A 58-Year-Old Woman With Pneumonia and Gram-Negative Diplococci. Chest. 2017 Oct;152(4):e95-e97. doi: 10.1016/j.chest.2017.05.037. PubMed PMID: 28991556.
9: Quinn D, Barnes CN, Yates W, Bourdet DL, Moran EJ, Potgieter P, Nicholls A, Haumann B, Singh D. Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies. Pulm Pharmacol Ther. 2017 Oct 4. pii: S1094-5539(17)30119-0. doi: 10.1016/j.pupt.2017.10.003. [Epub ahead of print] PubMed PMID: 28987804.
10: Portran P, Cour M, Hernu R, de la Salle S, Argaud L. Pupillary abnormalities in non-selected critically ill patients: an observational study. J Thorac Dis. 2017 Aug;9(8):2528-2533. doi: 10.21037/jtd.2017.07.58. PubMed PMID: 28932559; PubMed Central PMCID: PMC5594163.
11: Hou M, Li W, Xie Z, Ai J, Sun B, Tan G. Effects of anticholinergic agent on miRNA profiles and transcriptomes in a murine model of allergic rhinitis. Mol Med Rep. 2017 Nov;16(5):6558-6569. doi: 10.3892/mmr.2017.7411. Epub 2017 Aug 31. PubMed PMID: 28901404.
12: Duong HV, Herrera LN, Moore JX, Donnelly J, Jacobson KE, Carlson JN, Mann NC, Wang HE. National Characteristics of Emergency Medical Services Responses for Older Adults in the United States. Prehosp Emerg Care. 2017 Sep 1:1-8. doi: 10.1080/10903127.2017.1347223. [Epub ahead of print] PubMed PMID: 28862480.
13: Panduga V, Stocks MJ, Bosquillon C. Ipratropium is 'luminally recycled' by an inter-play between apical uptake and efflux transporters in Calu-3 bronchial epithelial cell layers. Int J Pharm. 2017 Oct 30;532(1):328-336. doi: 10.1016/j.ijpharm.2017.08.112. PubMed PMID: 28855136.
14: Nomura O, Morikawa Y, Hagiwara Y, Ihara T, Inoue N, Sakakibara H, Akasawa A. IPRATROPIUM BROMIDE FOR ACUTE ASTHMA IN CHILDREN: A RETROSPECTIVE TRIAL. Arerugi. 2017;66(7):945-952. doi: 10.15036/arerugi.66.945. Japanese. PubMed PMID: 28824036.
15: Halpin DM, Kaplan AG, Russell RK. Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators. Respir Med. 2017 Jul;128:28-41. doi: 10.1016/j.rmed.2017.04.008. Epub 2017 Apr 18. Review. PubMed PMID: 28610667.
16: Rehder KJ. Adjunct Therapies for Refractory Status Asthmaticus in Children. Respir Care. 2017 Jun;62(6):849-865. doi: 10.4187/respcare.05174. PubMed PMID: 28546381.
17: Lee TM, Tu K, Wing LL, Gershon AS. Identifying individuals with physician-diagnosed chronic obstructive pulmonary disease in primary care electronic medical records: a retrospective chart abstraction study. NPJ Prim Care Respir Med. 2017 May 15;27(1):34. doi: 10.1038/s41533-017-0035-9. PubMed PMID: 28507288; PubMed Central PMCID: PMC5435091.
18: Li X, Obeidat M, Zhou G, Leung JM, Tashkin D, Wise R, Connett J, Joubert P, Bossé Y, van den Berge M, Brandsma CA, Nickle DC, Hao K, Paré PD, Sin DD. Responsiveness to Ipratropium Bromide in Male and Female Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease. EBioMedicine. 2017 May;19:139-145. doi: 10.1016/j.ebiom.2017.04.020. Epub 2017 Apr 12. PubMed PMID: 28461224; PubMed Central PMCID: PMC5440622.
19: Liu X, Tang C, Xu H. Clinical effect of treatment on elderly chronic obstructive pulmonary disease combined with pulmonary tuberculosis. Pak J Pharm Sci. 2016 Nov;29(6 Spec):2255-2258. PubMed PMID: 28412691.
20: Bhandari SS, Koirala P, Lohani S, Phuyal P, Basnyat B. Breathlessness at High Altitude: First Episode of Bronchoconstriction in an Otherwise Healthy Sojourner. High Alt Med Biol. 2017 Jun;18(2):179-181. doi: 10.1089/ham.2017.0004. Epub 2017 Feb 21. PubMed PMID: 28398844.
